InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Benecchi Christopher. Insider active across 1 company, notably Sage Therapeutics, Inc.. Aggregated, 8 disclosures have been published. History available since 3 February 2023. The latest transaction was disclosed on 10 April 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Benecchi Christopher is a declarant linked to Sage Therapeutics, Inc., where he is Chief Operating Officer. The record shows 8 filings in total, and across the sampled recent filings between 2023-02-07 and 2025-07-31, the most frequent transaction nature is Attribution, with total buy and sell amounts shown as EUR 0.